Inhibitor Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2015
Period Ending	Mar '26 Mar 9, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2015
Market Capitalization	18	10	16	37	56	13	Upgrade
Market Cap Growth	-12.07%	-34.56%	-57.47%	-34.06%	332.17%	-36.77%	Upgrade
Enterprise Value	15	4	6	42	61	17	Upgrade
Last Close Price	0.11	0.06	0.09	0.10	0.15	0.03	Upgrade
PE Ratio	-	-	-	3.12	-	-	Upgrade
PB Ratio	5283.66	5.22	3.00	4.49	-15.59	-3.89	Upgrade
P/TBV Ratio	5283.66	5.22	3.00	4.49	-	-	Upgrade
P/OCF Ratio	-	-	-	3.17	-	-	Upgrade
Debt / Equity Ratio	20.75	-	-	0.05	-0.06	-0.03	Upgrade
Net Debt / Equity Ratio	-841.30	-2.82	-1.67	-1.39	-0.05	-0.01	Upgrade
Quick Ratio	34.01	7.90	13.29	17.61	0.05	0.18	Upgrade
Current Ratio	35.01	8.03	13.45	17.64	0.09	0.25	Upgrade
Return on Equity (ROE)	-200.97%	-91.88%	-44.57%	517.86%	-	-	Upgrade
Return on Assets (ROA)	-46.88%	-31.22%	-20.34%	-6.83%	-213.47%	-128.30%	Upgrade
Return on Capital Employed (ROCE)	-118.00%	-73.40%	-41.10%	-5.80%	52.40%	360.60%	Upgrade
Earnings Yield	-18.78%	-32.24%	-19.12%	32.53%	-0.53%	-8.10%	Upgrade
Buyback Yield / Dilution	-0.15%	-0.18%	53.04%	2.67%	-1.16%	-0.40%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.